PROVIDER PROFILE · NPI 1770623845
Kathryn Grambo
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,702
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
6
Brand share
80.3%
Top prescribed drugs
Dabigatran Etexilate Mesylate1,184 claims
Warfarin Sodium505 claims
Rivaroxaban476 claims
Apixaban391 claims
Dabigatran Etexilate Mesylate105 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE